Skip to content

Clinical trials

Phase 4 Pulmonary Disease, Chronic Obstructive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 4 Country / region: United States Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20046
20068
20073
20087
20095
20104
20116
20129
20135
20144
20155
20166
20178
20184
20194
20202
20211
20222
20231
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Terminated10
Recruiting5
Withdrawn5
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline23
Boehringer Ingelheim13
AstraZeneca4
Sumitomo Pharma America, Inc.4
Dartmouth-Hitchcock Medical Center2
Dayton VA Medical Center2
Johns Hopkins University2
University of Alabama at Birmingham2
University of California, Los Angeles2
Weill Medical College of Cornell University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive96
Bronchitis, Chronic9
Emphysema9
Asthma7
Dyspnea4
Coronary Artery Disease2
Lung Diseases2
Respiratory Aspiration2
Bone Diseases, Metabolic1
Bronchitis1

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.